Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 3 minute read Pharma Industry News Silexion Therapeutics completes key study on SIL-204 in pancreatic cancer models, initial results expected soon Silexion Therapeutics Corp. (NASDAQ: SLXN), a clinical-stage biotechnology company developing RNA interference therapy, has reached a major milestone… byPallavi MadhirajuFebruary 25, 2025